AMRI Starts Phase-I Study of Novel Drug for Obesity Treatment

Published July 24, 2010

AMRI starts phase-I study of novel drug for obesity treatment
AMRI has commenced enrolment for a phase-I study of ALB-127158(a), a novel MCH1 receptor antagonist offering a potential new approach for the treatment of obesity.
Read more on PharmaBiz

V.A. Easing Rules for Users of Medical Marijuana
Hospitals and clinics in the Department of Veterans Affairs system will formally allow veterans to use the drug in states where it is legal, though they will not prescribe it.
Read more on New York Times